The novel approach of the medication represents a major development in the management of the condition. Distinct from existing therapies, tirzepatide targets dual pathways – GLP-1 and GIP – resulting in improved https://tirzepatide-peptide167242.link4blogs.com/62862881/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment